Free Trial

agilon health, inc. (NYSE:AGL) Given Average Rating of "Hold" by Brokerages

→ The last Republican president? (From The Freeport Society) (Ad)
agilon health logo with Medical background

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been given an average recommendation of "Hold" by the seventeen research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $9.32.

Several research analysts have weighed in on the stock. Jefferies Financial Group restated a "hold" rating and set a $6.50 price objective (down previously from $25.00) on shares of agilon health in a report on Monday, February 26th. Stifel Nicolaus cut their price target on agilon health from $8.00 to $7.00 and set a "hold" rating for the company in a research note on Wednesday, May 1st. Royal Bank of Canada lowered their price objective on agilon health from $11.00 to $8.00 and set an "outperform" rating for the company in a research note on Wednesday, February 28th. Benchmark cut their target price on agilon health from $13.00 to $9.00 and set a "buy" rating on the stock in a research report on Thursday, February 29th. Finally, Truist Financial lowered their price target on agilon health from $10.00 to $7.50 and set a "hold" rating for the company in a research report on Thursday, February 29th.

Get Our Latest Research Report on agilon health

agilon health Stock Up 5.6 %

Shares of AGL stock traded up $0.29 on Tuesday, reaching $5.50. 6,427,643 shares of the company were exchanged, compared to its average volume of 5,543,282. agilon health has a one year low of $4.41 and a one year high of $24.15. The company has a market cap of $2.26 billion, a price-to-earnings ratio of -7.86 and a beta of 0.52. The company has a 50-day moving average of $5.28 and a 200-day moving average of $8.31. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33.


agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.13). agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the previous year, the company posted ($0.14) EPS. The firm's revenue was up 71.8% on a year-over-year basis. Analysts anticipate that agilon health will post -0.34 earnings per share for the current year.

Institutional Investors Weigh In On agilon health

Large investors have recently modified their holdings of the stock. Wellington Management Group LLP boosted its holdings in agilon health by 8.3% in the 3rd quarter. Wellington Management Group LLP now owns 41,318,777 shares of the company's stock worth $733,821,000 after buying an additional 3,162,094 shares during the period. California Public Employees Retirement System raised its stake in shares of agilon health by 27.7% during the 3rd quarter. California Public Employees Retirement System now owns 413,987 shares of the company's stock valued at $7,352,000 after purchasing an additional 89,728 shares during the period. Morgan Stanley lifted its holdings in agilon health by 8.9% during the 3rd quarter. Morgan Stanley now owns 44,819,378 shares of the company's stock worth $795,992,000 after purchasing an additional 3,674,311 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in agilon health by 4.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,796,884 shares of the company's stock worth $31,913,000 after purchasing an additional 70,443 shares during the period. Finally, Tower Research Capital LLC TRC boosted its stake in agilon health by 222.5% in the 3rd quarter. Tower Research Capital LLC TRC now owns 23,660 shares of the company's stock worth $420,000 after purchasing an additional 16,324 shares during the period.

About agilon health

(Get Free Report

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Analyst Recommendations for agilon health (NYSE:AGL)

→ The Key to this $10 Trillion Tech Boom (From Porter & Company) (Ad)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Cathie Wood’s AMD Buy: Smart Move or Risky Business

Cathie Wood’s AMD Buy: Smart Move or Risky Business

Discover how Cathie Wood's bold move influences investor sentiment towards AMD and how AMD stacks up against competitors like Intel and NVIDIA in the semiconductor industry.

Related Videos

AMD is Down 35%. Now is the Time to Buy the Dip
Skip Nvidia: Finding AI Stocks Beyond the Buzz
Crafting Your Portfolio’s Magnificent Seven: Top Stocks for 2024

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines